One hundred years of aspirin
Level 5 - mechanism / opinion, no new human data
Level 5 by design analogy; qualitative historical analysis and archival review without clinical or experimental data.
OpenAlex W1969124854 · doi:10.1017/s0025727300065728
What was done
The author performed a historical investigation comparing the traditional account of aspirin's development at Bayer (synthesis by Felix Hoffmann on 10 August 1897 and testing by Heinrich Dreser) with historical documentation, including archival material from Bayer and a retrospective letter written by chemist Arthur Eichengrün.
What was found
The abstract reports historical chronology rather than statistical findings: acetylsalicylic acid was synthesized in 1853 by Gerhardt, sold in the 1880s by Merck, re-synthesized on 10 August 1897 by Hoffmann, named Aspirin on 23 January 1899, and registered on 6 March 1899. Archival evidence and subsequent publications support Arthur Eichengrün's contention that aspirin's development was the product of collaborative teamwork, trial and error, and corporate politics rather than an individual discovery by Hoffmann.
Why it matters
It provides historical correction to the standard corporate narrative of one of the world's most widely used pharmaceuticals, highlighting the overlooked contribution of Arthur Eichengrün.
Limits
The work is a qualitative historical note based on narrative interpretation of surviving archival documents and retrospective accounts. The abstract provides no empirical, quantitative, or clinical data.
Cited by
- context Aspirin was discovered in 1899 by the German company Bayer.